Detailed information for compound 182909

Basic information

Technical information
  • TDR Targets ID: 182909
  • Name: (2R,3S)-4-acetyl-N-hydroxy-3-methyl-1-[4-[(2- methylphenyl)methoxy]phenyl]sulfonylpiperazin e-2-carboxamide
  • MW: 461.531 | Formula: C22H27N3O6S
  • H donors: 2 H acceptors: 5 LogP: 1.49 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: ONC(=O)[C@H]1[C@H](C)N(CCN1S(=O)(=O)c1ccc(cc1)OCc1ccccc1C)C(=O)C
  • InChi: 1S/C22H27N3O6S/c1-15-6-4-5-7-18(15)14-31-19-8-10-20(11-9-19)32(29,30)25-13-12-24(17(3)26)16(2)21(25)22(27)23-28/h4-11,16,21,28H,12-14H2,1-3H3,(H,23,27)/t16-,21+/m0/s1
  • InChiKey: SBPPAFQZTZUQSW-HRAATJIYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • (2R,3S)-4-acetyl-3-methyl-1-[4-(o-tolylmethoxy)phenyl]sulfonyl-piperazine-2-carbohydroxamic acid
  • (2R,3S)-4-acetyl-3-methyl-1-[4-(o-tolylmethoxy)phenyl]sulfonyl-2-piperazinecarbohydroxamic acid
  • (2R,3S)-4-ethanoyl-N-hydroxy-3-methyl-1-[4-[(2-methylphenyl)methoxy]phenyl]sulfonyl-piperazine-2-carboxamide
  • (2R,3S)-4-acetyl-3-methyl-1-[4-(2-methylbenzyl)oxyphenyl]sulfonyl-piperazine-2-carbohydroxamic acid
  • (2R,3S)-4-acetyl-3-methyl-1-[4-[(2-methylphenyl)methoxy]phenyl]sulfonyl-piperazine-2-carbohydroxamic acid
  • (2R,3S)-4-acetyl-3-methyl-1-[4-[(2-methylphenyl)methoxy]phenyl]sulfonyl-2-piperazinecarbohydroxamic acid

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens matrix metallopeptidase 13 (collagenase 3) Starlite/ChEMBL References
Homo sapiens matrix metallopeptidase 1 (interstitial collagenase) Starlite/ChEMBL References
Homo sapiens ADAM metallopeptidase domain 17 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis adam 17 protease Get druggable targets OG5_132656 All targets in OG5_132656
Echinococcus granulosus Blood coagulation inhibitor Disintegrin Get druggable targets OG5_132656 All targets in OG5_132656
Schistosoma mansoni ADAM17 peptidase (M12 family) Get druggable targets OG5_132656 All targets in OG5_132656
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132656 All targets in OG5_132656
Echinococcus multilocularis Blood coagulation inhibitor, Disintegrin Get druggable targets OG5_132656 All targets in OG5_132656
Echinococcus granulosus adam 17 protease Get druggable targets OG5_132656 All targets in OG5_132656
Schistosoma japonicum ko:K06059 a disintegrin and metalloproteinase domain 17, putative Get druggable targets OG5_132656 All targets in OG5_132656

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi Disintegrin family protein ADAM metallopeptidase domain 17 824 aa 724 aa 27.4 %
Brugia malayi Matrixin family protein matrix metallopeptidase 1 (interstitial collagenase) 403 aa 401 aa 27.7 %
Echinococcus granulosus matrix metallopeptidase 7 M10 family matrix metallopeptidase 13 (collagenase 3) 471 aa 448 aa 34.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0468 0.8478 0.8478
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Brugia malayi Matrixin family protein 0.0053 0.0204 0.0204
Loa Loa (eye worm) matrixin family protein 0.0127 0.1689 0.1689
Trichomonas vaginalis bromodomain-containing protein 4, brd4, putative 0.0246 0.4061 0.4061
Plasmodium falciparum bromodomain protein, putative 0.0042 0 0.5
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Loa Loa (eye worm) hypothetical protein 0.0053 0.0204 0.0204
Trichomonas vaginalis bromodomain-containing protein, putative 0.0341 0.5939 0.5939
Schistosoma mansoni CREB-binding protein 2 0.0144 0.2015 0.2015
Onchocerca volvulus Matrix metalloproteinase homolog 0.0117 0.1479 0.3643
Trichomonas vaginalis histone acetyltransferase gcn5, putative 0.0246 0.4061 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Brugia malayi Bromodomain containing protein 0.0545 1 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Onchocerca volvulus Matrilysin homolog 0.0053 0.0204 0.0502
Plasmodium vivax histone acetyltransferase GCN5, putative 0.0042 0 0.5
Schistosoma mansoni adam (A disintegrin and metalloprotease 0.007 0.0551 0.0551
Trichomonas vaginalis bromodomain-containing protein, putative 0.0341 0.5939 0.5939
Trichomonas vaginalis bromodomain-containing protein, putative 0.0341 0.5939 0.5939
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Trichomonas vaginalis bromodomain containing protein, putative 0.0341 0.5939 0.5939
Schistosoma mansoni bromodomain-containing protein 3 brd3 0.0545 1 1
Brugia malayi Matrix metalloprotease, N-terminal domain containing protein 0.0064 0.0432 0.0432
Schistosoma mansoni ADAMTS5 peptidase (M12 family) 0.0151 0.216 0.216
Schistosoma mansoni hypothetical protein 0.0054 0.023 0.023
Plasmodium vivax bromodomain protein, putative 0.0042 0 0.5
Echinococcus granulosus ATPase family AAA domain containing protein 2B 0.0096 0.1074 0.1074
Brugia malayi ADAMTS-like protease 0.005 0.0153 0.0153
Brugia malayi angiogenesis inhibito 0.005 0.0153 0.0153
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Brugia malayi Matrixin family protein 0.0053 0.0204 0.0204
Echinococcus multilocularis adam 17 protease 0.0223 0.3592 0.3592
Loa Loa (eye worm) hypothetical protein 0.0048 0.0109 0.0109
Giardia lamblia Kinase, putative 0.0246 0.4061 1
Toxoplasma gondii bromodomain-containing protein 0.0246 0.4061 1
Echinococcus granulosus Blood coagulation inhibitor Disintegrin 0.014 0.194 0.194
Onchocerca volvulus Matrilysin homolog 0.0117 0.1479 0.3643
Brugia malayi hypothetical protein 0.007 0.0551 0.0551
Brugia malayi metalloprotease disintegrin 16 with thrombospondin type I motif 0.0105 0.1251 0.1251
Mycobacterium ulcerans hydrolase 0.0064 0.0432 0.5
Loa Loa (eye worm) bromodomain containing protein 0.0246 0.4061 0.4061
Mycobacterium tuberculosis Probable peptidoglycan hydrolase 0.0064 0.0432 0.5
Entamoeba histolytica bromodomain-containing protein 0.0246 0.4061 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Schistosoma mansoni ADAM17 peptidase (M12 family) 0.0223 0.3592 0.3592
Plasmodium vivax hypothetical protein, conserved 0.0042 0 0.5
Loa Loa (eye worm) CBP-B 0.0112 0.1388 0.1388
Echinococcus multilocularis Blood coagulation inhibitor, Disintegrin 0.014 0.194 0.194
Trypanosoma cruzi ATPase, putative 0.0054 0.023 1
Echinococcus granulosus matrix metallopeptidase 7 M10 family 0.0191 0.2965 0.2965
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Trichomonas vaginalis conserved hypothetical protein 0.0298 0.5096 0.5096
Plasmodium vivax bromodomain protein, putative 0.0042 0 0.5
Brugia malayi ADAM-TS Spacer 1 family protein 0.0126 0.1661 0.1661
Mycobacterium leprae PROBABLE HYDROLASE 0.0064 0.0432 0.5
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Echinococcus granulosus bromodomain containing 2 0.0545 1 1
Echinococcus granulosus a disintegrin and metalloproteinase with 0.0151 0.216 0.216
Entamoeba histolytica bromodomain-containing protein 0.0246 0.4061 1
Plasmodium vivax bromodomain protein, putative 0.0042 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0545 1 1
Echinococcus granulosus CREB binding protein 0.0144 0.2015 0.2015
Echinococcus multilocularis ATPase family AAA domain containing protein 2B 0.0096 0.1074 0.1074
Plasmodium vivax conserved Plasmodium protein, unknown function 0.0042 0 0.5
Brugia malayi Matrixin family protein 0.0053 0.0204 0.0204
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Loa Loa (eye worm) matrix metalloproteinase 0.0053 0.0204 0.0204
Onchocerca volvulus 0.0053 0.0204 0.0502
Trichomonas vaginalis bromodomain-containing protein, putative 0.0545 1 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Echinococcus granulosus CREB binding protein 0.0104 0.1229 0.1229
Echinococcus multilocularis bromodomain containing 2 0.0545 1 1
Echinococcus multilocularis matrix metallopeptidase 7 (M10 family) 0.0191 0.2965 0.2965
Loa Loa (eye worm) hypothetical protein 0.0064 0.0432 0.0432
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Loa Loa (eye worm) hypothetical protein 0.0053 0.0204 0.0204
Onchocerca volvulus 0.0075 0.0642 0.158
Schistosoma mansoni matrix metallopeptidase-7 (M10 family) 0.0053 0.0204 0.0204
Onchocerca volvulus 0.0246 0.4061 1
Brugia malayi TAZ zinc finger family protein 0.0144 0.2015 0.2015
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Trichomonas vaginalis conserved hypothetical protein 0.0341 0.5939 0.5939
Echinococcus multilocularis adam 0.007 0.0551 0.0551
Trichomonas vaginalis bromodomain-containing protein, putative 0.0545 1 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Loa Loa (eye worm) matrixin family protein 0.0117 0.1479 0.1479
Echinococcus granulosus adam 0.007 0.0551 0.0551
Echinococcus granulosus adam 17 protease 0.0245 0.4035 0.4035
Brugia malayi Hemopexin family protein 0.0075 0.0642 0.0642
Loa Loa (eye worm) hypothetical protein 0.0048 0.0119 0.0119
Trichomonas vaginalis conserved hypothetical protein 0.0246 0.4061 0.4061
Entamoeba histolytica bromodomain-containing protein 0.0246 0.4061 1
Trichomonas vaginalis bromodomain containing protein, putative 0.0246 0.4061 0.4061
Plasmodium falciparum bromodomain protein 1 0.0042 0 0.5
Echinococcus multilocularis CREB binding protein 0.0111 0.137 0.137
Loa Loa (eye worm) hypothetical protein 0.0126 0.1661 0.1661
Trypanosoma brucei AAA ATPase, putative 0.0096 0.1074 1
Brugia malayi Matrixin family protein 0.0127 0.1689 0.1689
Plasmodium vivax SET domain containing protein 0.0042 0 0.5
Echinococcus multilocularis a disintegrin and metalloproteinase with 0.0151 0.216 0.216
Schistosoma mansoni CREB-binding protein 1 (SmCBP1) 0.0144 0.2015 0.2015
Brugia malayi Matrixin family protein 0.0053 0.0204 0.0204
Brugia malayi ATPase, AAA family protein 0.0096 0.1074 0.1074
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Loa Loa (eye worm) hypothetical protein 0.0096 0.1074 0.1074
Leishmania major ATPase, putative 0.0054 0.023 1
Loa Loa (eye worm) hypothetical protein 0.0053 0.0204 0.0204
Plasmodium falciparum bromodomain protein 2, putative 0.0042 0 0.5
Brugia malayi hypothetical protein 0.0204 0.3217 0.3217
Trichomonas vaginalis bromodomain-containing protein, putative 0.0246 0.4061 0.4061
Schistosoma mansoni hypothetical protein 0.0075 0.0642 0.0642
Echinococcus multilocularis Bromodomain containing protein 0.0246 0.4061 0.4061

Activities

Activity type Activity value Assay description Source Reference
Clp (ADMET) = 54 ml min-1 kg-1 Pharmacokinetic property (Clp) of the compound was determined in rat ChEMBL. 12951101
ED50 (functional) = 17 mg kg-1 Concentration of the compound required for TNF-alpha production in an acute rat LPS-induced model ChEMBL. 12951101
IC50 (binding) = 3 nM In vitro inhibition of matrix metalloprotease-13. ChEMBL. 12951101
IC50 (binding) = 3 nM In vitro inhibition of matrix metalloprotease-13. ChEMBL. 12951101
IC50 (binding) = 6 nM Inhibition of human recombinant tumor necrosis factor-alpha converting enzyme. ChEMBL. 12951101
IC50 (binding) = 6 nM Inhibition of human recombinant tumor necrosis factor-alpha converting enzyme. ChEMBL. 12951101
IC50 (binding) = 1600 nM In vitro inhibition of matrix metalloprotease-1. ChEMBL. 12951101
IC50 (binding) = 1600 nM In vitro inhibition of matrix metalloprotease-1. ChEMBL. 12951101
IC50 (functional) = 1 uM Inhibition of Tumor necrosis factor-alpha (TNF-alpha) release in human whole blood ChEMBL. 12951101
IC50 (functional) = 1 uM Inhibition of Tumor necrosis factor-alpha (TNF-alpha) release in human whole blood ChEMBL. 12951101
T1/2 (ADMET) = 0.27 hr Half life of the compound was determined in rat i.v. ChEMBL. 12951101
Vdss (ADMET) = 0.6 l kg-1 Pharmacokinetic property (Vdss) of the compound was determined in rat ChEMBL. 12951101

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.